https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

Research News – Monday, April 29, 2024


Published: Monday, April 29, 2024

NEWS CLIP! One Scientist Neglected His Grant Reports. Now U.S. Agencies Are Withholding Grants for an Entire University.
 
 
Notices and Reminders
 
NIH is implementing multiple changes that will impact the preparation and peer review of most grant applications submitted to NIH for due dates on or after January 25, 2025.
 
 
Workshops and Seminars
 
NIH Health Sciences Innovation and Entrepreneurship (HSE) Seminar Series
Funding for Early- Career Scientists to Commercialize Cancer Technologies
Online Friday, May 10, 2024, 12PM-1PM-CT
See attached flyer for additional information
 
An Introduction to HELIOS Open Scholarship
Tuesday, May 7, 2024, 10 a.m. – 11:30 a.m. CT
Please join us to learn more about the Higher Education Leadership Initiative for Open Scholarship (HELIOS Open) and its importance to research at OU from a panel of experts working in this area. HELIOS Open seeks to promote a more transparent, inclusive, and trustworthy research ecosystem. Panelists include Danny Anderson, President Emeritus of Trinity University, Geeta Swamy, HELIOS Open Strategic Lead & Duke University Associate Vice President for Research & Vice Dean for Science Integrity, and Caitlin Carter, HELIOS Open Program Manager. There will be time for Q & A with the panelists following the presentation. This program is hosted by the OU HELIOS Advisory Council.
Event Venue/Location: Zoom link will be provided after registration. 
Point of contact: Sarah Robbins, srobbins@ou.edu.
 
 
OUHSC Funding Opportunities
 
The Sooner Heritage Scholarship program was established in 2003, especially to help those middle-income students who may not qualify for sufficient federal assistance and still need a helping hand with college expenses.
Any OU Health Sciences Center (HSC) student is eligible to receive Sooner Heritage Scholarships with these caveats:
  • A 2024-2025 FAFSA is on file with our office, and
  • The Sooner Heritage Scholarship application must be completed (see
instructions attached), and
  • Undergraduate students must be enrolled in at least six hours per semester to
qualify, or graduate/professional students must be enrolled in at least five hours per semester.
  • Sooner Heritage Scholarship funds are for Fall and Spring terms, but are not
processed for the Summer term.
The Sooner Heritage application can be found by logging into your student Self-Service here. Navigate to the Student Center and you will find a link to the application on the right under Online Forms.
 
 
The Pew Biomedical Scholars program provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program awards grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the Assistant Professor level. The 2025 award will be in the amount of $300,000 ($75,000 per year for four years). Eligible faculty are invited to submit an internal pre-proposal via email to HSCORA@ouhsc.edu by 5 pm on May 6, 2024. Details can be found in the attached announcement. 
 
 
Oklahoma Biotech Startup Programs Concept Program
OKBioStart Program is a grant-funded, multi-institutional program for innovators, founders, and the life science community in the greater Oklahoma City ten-county region that accelerates the translation of innovative concepts into commercially viable life sciences (Biotech, MedTech, or Virtual Health) technologies.  See program announcement attached for specific deadline dates associated with each program.
 
Center for Indigenous Resilience, Culture, and Maternal Health Equity (CIRCLE) Request for Letters of Intent: Pilot Projects
Description: The CIRCLE Pilot Projects program seeks to support novel clinical and translational ideas that impact the understanding and solution of Indigenous maternal mortality and morbidity (MMM) or maternal health disparities. This program will support proposals designed to generate preliminary data that enhances the competitiveness of the investigators for extramural funding while furthering our understanding of MMM to improve maternal health outcomes for Indigenous mothers in Oklahoma and the Southern Plains. CIRCLE plans to fund up to 4 pilot projects in 2024 for up to $25,000 each.
Deadline for Letters of Intent: May 1, 2024
Link to the Full Announcement: Please see attached (CIRCLE pilot project application 2024)
 
Office of Technology Commercialization presents the following opportunity for
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  
An American pharmaceutical company focused on rare diseases seeks novel therapeutics with defined target, mechanism of action and proven efficacy for non-malignant hematological diseases.  Modalities of interest include small molecule, RNA-based, proteins/peptides and antibodies.  Therapeutics that act on SPHK1, HRI, BCL11A and ALAS2 are of particular interest.  Out of scope:  cell and gene therapies, repurposed or reformulated drugs, and treatments that act on LRF/SBTB7A, EED complex, LSD1, HIF-PHIs and TcRNs.   Submission entails a one-page 200-300 word non-confidential brief.  Deadline May 20th.
LifeArc, a non-profit medical research organization, is seeking innovative proposals to boost drug repurposing in motor neuron disease.  Approaches of interest include preclinical stage research with a repurposed drug or drug combination.  Submission of an Expression of Interest form is required as part of the application process; more information can be found at the LifeArc – Drug Repurposing in MND.    
Deadline May 10th.
 
 
 
 
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.
 
NIH Funding Opportunities
 
 
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) (PA-24-176)
Application Deadline:  June 12, 2024 and October 12, 2024

Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) (PA-24-177)
Application Deadline:  June 12, 2024 and October 12, 2024

Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
(PA-24-178)
Application Deadline:  June 12, 2024 and October 12, 2024

Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
(PA-24-179)
Application Deadline:  June 12, 2024 and October 12, 2024
 
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) (PA-24-180)
Application Deadline: June 12, 2024 and October 12, 2024
 
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) (PA-24-187)
Application Deadline:  June 12, 2024 and October 12, 2024
 
 
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) (PA-24-190)
Application Deadline:  June 12, 2024 and October 12, 2024
 
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) (PA-24-193)
Application Deadline:  June 12, 2024 and October 12, 2024
 
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) (PA-24-194)
Application Deadline:  June 12, 2024 and October 12, 2024
 
 
 
 
 
 
Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed) (RFA-AI-24-025)
Application Deadline:  October 9, 2024
 
 
 
Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
(RFA-DK-25-004)
Application Deadline:  October 17, 2024
 
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
(RFA-DK-25-010)
Application Deadline:  July 17, 2024
 
 
Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional
(RFA-FD-24-041)
Application Deadline:  July 3, 2024
 
 
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
(RFA-HL-26-002)
Application Deadline:  February 19, 2025
 
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
(RFA-HL-26-003)
Application Deadline:  February 19, 2025
 
 
 
OTHER Funding Opportunities
 
TELLIGEN — Strengthening Families and Communities
Applications for Strengthening Families and Communities grants are due July 2, 2024.     To support projects that address the following themes:
  • Pre-pregnancy and pregnancy - healthy births.
  • School readiness and school health.
  • Healthy parenting skill development / strengthening family supports.
  • Adverse Childhood Experiences (ACE) prevention / protective factors. 
Nonprofits from all four states, including Colorado, Illinois, Iowa and Oklahoma, can apply for this funding opportunity. In addition, the per-grant maximum award is now $75,000 to more adequately address the project scope presented in many worthy applications that we have received in the past. 

Documents to download